Entrada Therapeutics
Develops medicines that target and treat previously inaccessible intracellular diseases.
Company facts
- Founded
- 2016
- Employees
- 152
- Headquarters
- United States
- Type
- Public
- Listed
- Nasdaq: TRDA
- Subsidiaries
- Entrada Securities Corporation